Li-Cor supports virology research for COVID-19

By The Science Advisory Board staff writers

July 7, 2020 -- Li-Cor Biosciences offers research solutions for therapeutics development and western blotting. Now, the company is offering researchers a special Odyssey Clx Viral Solution package at a reduced price to support COVID-19 research.

Traditionally, researchers use plaque assays to determine infectivity of SARS-CoV-2 and other viruses. Alternatively, Li-Cor's near-infrared western blot and in-cell western assays offer a rapid and reliable method to study viruses like SARS-CoV-2.

The package includes the Odyssey Imager, startup reagents, basic and advanced virtual training from Li-Cor scientists, and Empiria Studio statistical analysis software.

Copyright © 2020

Register below for our weekly Letter from the Editor to receive the latest Science news and insights.
2020 ACCP Annual Meeting
September 20-22
Bethesda, Maryland United States
Bioprocess International West
September 21-24
Eastern Standard Time Zone (EST) United States
BioProcess International
September 21-24
Eastern Standard Time Zone (EST), Massachusetts United States
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter